Leanne Kelly

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Leanne Kelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leanne Kelly:

Company Role Class Num Shares Value Price $ Report Date Ownership
GRI Bio, Inc. Chief Financial Officer Stock Option (Right to Buy) 43,222 $29,704 $0.6857 18 Sep 2025 Direct

Insider Reports Filed by Leanne Kelly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GRI GRI Bio, Inc. 18 Sep 2025 1 $0 4 Chief Financial Officer 22 Sep 2025, 16:06
GRI GRI Bio, Inc. 26 Aug 2025 1 $0 4 Chief Financial Officer 27 Aug 2025, 08:24
GRI GRI Bio, Inc. 23 Jan 2025 1 +$29,704 4 Chief Financial Officer 24 Jan 2025, 17:58
WINT WINDTREE THERAPEUTICS INC /DE/ 08 Jan 2025 0 $0 3 Director 14 Jan 2025, 16:17
GRI GRI BIO, Inc. 22 Sep 2023 1 +$126,666 4 Chief Financial Officer 26 Sep 2023, 17:08
GRI Vallon Pharmaceuticals, Inc. 15 Feb 2022 1 +$281,500 4 Chief Financial Officer 01 Mar 2022, 16:03
GRI Vallon Pharmaceuticals, Inc. 02 Jun 2021 3 +$25,175 4 Chief Financial Officer 04 Jun 2021, 16:06
GRI Vallon Pharmaceuticals, Inc. 14 May 2021 1 $0 4 Chief Financial Officer 18 May 2021, 16:07
GRI Vallon Pharmaceuticals, Inc. 11 May 2021 0 $0 3 Chief Financial Officer 18 May 2021, 16:05